WISeKey END2END SECURE DIGITAL MEDICAL DEVICES

WISeKey cybersecurity, IoT, AI, and Identity Management technologies are increasingly used to digitally certify and encrypt the data originated sensor that can be used for immediate tests for the new SARS coronavirus. In the last month, WISeKey was selected by Digital Diagnostics AG, a German health tech company to enable AI-based real-time diagnostics of human biodata, and lately by ClinIQ Inc working with Oxford University Innovation to launch VirusIQ , a screening platform that specialises in early detection, prevention, and management of virus diseases such as COVID-19.

The new digital diagnostic platform enables the rapid testing of millions of people and thus enables real-time monitoring of the spread of the disease within the population. By connecting the digital sensor to a secure database, new regional hotspots of the virus spread can be recognized in real-time and immediately contained.

Many governments are looking for paths out of restrictive physical distancing measures imposed to control the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With a potential vaccine against coronavirus disease 2019 (COVID-19) many months away these type of tests allows authorities to use the huge data flow generated by these devices to make decisions.